Reply: to comment on "Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation" AND "Lack of stroke subtype information may hinder indirect comparison between the ROCKET-AF and other trials of new oral anticoagulants"

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

1 Citationer (Scopus)
346 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftJournal of the American College of Cardiology
Vol/bind61
Udgave nummer5
Sider (fra-til)596
ISSN0735-1097
DOI
StatusUdgivet - 5 feb. 2013

Bibliografisk note

Reply to , "Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation" Journal of the American College of Cardiology (ISSN 0735-1097), 2012, vol. 60, iss. 8, p. 738-46. AND
"Lack of stroke subtype information may hinder indirect comparison between the ROCKET-AF and other trials of new oral anticoagulants" Journal of the American College of Cardiology (ISSN 0735-1097), 2013, vol. 61, iss. 5, p. 595-6.

Citationsformater